Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma

Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma

Background: Cervical squamous cell carcinoma (CESC) is one of the most common causes of cancer-related death worldwide. N6-methyladenosine (m6A) plays an important role in various cellular responses by regulating mRNA biology. This study aimed to develop and validate an m6A RNA methylation regulator...

Full description

Bibliographic Details
Main Authors: Jingxin Pan, Lichao Xu, Hongda Pan
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-08-01
Series:Frontiers in Oncology
Subjects:
m6A
RNA methylation
cervical squamous cell carcinoma
prognosis
experimental validation
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01444/full

Similar Items

Similar Items